Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia

PHASE4CompletedINTERVENTIONAL
Enrollment

219

Participants

Timeline

Start Date

January 31, 2001

Study Completion Date

June 30, 2002

Conditions
Community-Acquired Pneumonia (CAP)
Interventions
DRUG

IV azithromycin

500 mg once daily

DRUG

ceftriaxone

1 gram once daily for 2 to 5 days

DRUG

oral azithromycin

2 x 250 mg once daily

DRUG

IV levofloxacin

500 mg once daily

DRUG

oral levofloxacin

500 mg once daily

Trial Locations (37)

10003

Pfizer Investigational Site, New York

11501

Pfizer Investigational Site, Mineola

15126

Pfizer Investigational Site, Maroussi. Attikis

18960

Pfizer Investigational Site, Sellersville

19140

Pfizer Investigational Site, Philadelphia

27103

Pfizer Investigational Site, Winston-Salem

30905

Pfizer Investigational Site, Fort Gordon

31902

Pfizer Investigational Site, Columbus

31904

Pfizer Investigational Site, Columbus

34339

Pfizer Investigational Site, Sarasota

35233

Pfizer Investigational Site, Birmingham

40206

Pfizer Investigational Site, Louisville

43202

Pfizer Investigational Site, Columbus

44106

Pfizer Investigational Site, Cleveland

48202

Pfizer Investigational Site, Detroit

63110

Pfizer Investigational Site, St Louis

63122

Pfizer Investigational Site, Kirkwood

66204

Pfizer Investigational Site, Shawnee Mission

78229

Pfizer Investigational Site, San Antonio

90822

Pfizer Investigational Site, Long Beach

91342

Pfizer Investigational Site, Sylmar

48073-6769

Pfizer Investigational Site, Royal Oak

87108-5154

Pfizer Investigational Site, Albuquerque

R3A 1R9

Pfizer Investigational Site, Winnipeg

B3H 3A7

Pfizer Investigational Site, Halifax

L8V 1C3

Pfizer Investigational Site, Hamilton

N6A 4G5

Pfizer Investigational Site, London

K1Y 4E9

Pfizer Investigational Site, Ottawa

H1T 2M4

Pfizer Investigational Site, Montreal

G1V 4G5

Pfizer Investigational Site, Ste-foy

S4P 1Z7

Pfizer Investigational Site, Regina

S7L 2W1

Pfizer Investigational Site, Saskatoon

D-27356

Pfizer Investigational Site, Rotenburg (Wümme)

D-14109

Pfizer Investigational Site, Berlin

D58515

Pfizer Investigational Site, Lüdenscheid

08036

Pfizer Investigational Site, Barcelona

08221

Pfizer Investigational Site, Tarrasa

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY